HGT-1110

· Shire

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HGT-1110, covering 2018-10-15 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy [Phase 1, Phase 2]